With recent FDA approvals fueling excitement in metabolic research, our upcoming webinar will explore how multimodal imaging — from IVIS? optical to Quantum? microCT and Vega? ultrasound — can deepen insights into metabolic diseases like type 2 diabetes and obesity. Don’t miss this chance to see how these tools can elevate your research! Register now! https://ms.spr.ly/6040W9FyY
关于我们
Transforming innovation from target to cure. Revvity delivers end-to-end expertise and solutions from research discovery to development, and diagnosis to cure. Our scalable, end-to-end workflows are uniquely positioned to meet your needs – from basic research through to the development of new drugs. Our team introduces roughly 1,500 new life science antibodies, kits and reagents annually and 47 of the world's top 50 pharma companies use our discovery solutions and services to work towards finding novel therapeutics. Learn why here: www.revvity.com
- 网站
-
https://www.revvity.com/
Revvity for Life Sciences的外部链接
- 所属行业
- 生物技术研究
- 规模
- 5,001-10,000 人
动态
-
Join us on December 5th for a comprehensive webinar on therapeutic payload and delivery. https://ms.spr.ly/6049WcPYP Hear our experts discuss the latest advancements in our AAV evolution, learn about LentBOOST? technology and its potential to enhance transduction efficiency, and explore innovative gene editing platforms like Pin-point?. #cellandgenetherapy #celltherapy #genetherapy
-
-
From disease tracking to drug efficacy, our bioluminescence and fluorescence platforms, along with our reagents, offer the insights you need. Book time with Sid Jandhyala, Ph.D. to discover how. https://ms.spr.ly/6045Wq9YF Explore IVIS? platforms and reagents here: https://ms.spr.ly/6046Wq9Y2
-
Discover the future of treating neurodegenerative diseases like Alzheimer’s, Parkinson’s, and Huntington’s with gene therapy! Our latest white paper dives deep into innovative genome editing tools, advanced RNA editing, and the crucial role of viral vectors in targeting the central nervous system. https://ms.spr.ly/6045WwPER Learn about the latest approved therapies, ongoing clinical trials, and the promising future of gene therapy as a treatment for neurodegenerative diseases. Don’t miss out on this comprehensive white paper to the next frontier in medical science! #GeneTherapy #NeurodegenerativeDiseases
-
-
Streamline your #CRISPR workflows with Dharmacon? All-in-one reagents. Our innovative platform integrates #CRISPR nuclease and single guide #RNA into one lentiviral vector, offering the simplest gene knockout/modulation solution for any human or mouse gene. Achieve rapid results, whether you're working on single gene experiments or scaling up to whole-genome screens. https://ms.spr.ly/6045md8RP #Dharmacon #CRISPRa #CRISPRi
-
-
Hello from #AZDISC come and meet your #Revvity team #DrugDiscovery #HTRF #AlphaLISA #siRNA #celllines #CRISPR #NGS #HCS
-
-
Our new white paper explores multispecific antibody formats and therapeutic applications, along with their advantages and challenges. Learn more! https://ms.spr.ly/6040Ww3ke Key highlights: ? Common multispecific antibody formats ? Advantages of using multispecific antibodies over monospecific antibodies ? Therapeutic applications of multispecific antibodies ? Impacts of multispecific format on safety and development
-
-
Discover Revvity’s newest assay using HTRF technology to detect double-stranded RNA research for in vivo gene therapy studies! Shop Now https://ms.spr.ly/6040WncWk
-
-
We really enjoyed attending and presenting at AMP 2024. Contact us to discuss how we can support your oncology workflows further: https://ms.spr.ly/6041mxSd9 #AMPATH24 #AMPlifier
-
Calling all lab enthusiasts! Presenting our first edition of Lab Efficiency News. Be sure to subscribe to this monthly newsletter. #labautomation #labnews #smartlabs #automatedworkflows #labefficiency